Links -> Link Details
| Title | Chemotherapy-induced Peripheral Neuropathy Market - Dynamics, Size, And Opportunity Forecast To 2030 |
|---|---|
| URL | https://www.astuteanalytica.com/industry-report/chemotherapy-induced-peripheral-neuropathy-market |
| Category | Business --> Pharmaceuticals |
| Meta Keywords | Chemotherapy-induced peripheral neuropathy Market |
| Meta Description | 7MM Chemotherapy-Induced Peripheral Neuropathy market is estimated to grow at a CAGR of 5.16% during the forecast period 2022-2030. |
| Owner | Eric darnner |
| Description | |
| The players profiled in the report include the following – Solacia Pharma K.K., Wex Pharmaceutical, Regenacy Pharmaceutical LLC, MAK Scientific, Apexiam Pharmaceutical, Osmol Therapeutics, Egetis Therapeutics, Algo Therapeutix, Asahi Kasei Pharma, and Kannalife Sciences Inc. | |